SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-023883
Filing Date
2017-01-30
Accepted
2017-01-30 17:26:03
Documents
7
Period of Report
2017-01-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d319880d8k.htm 8-K 28252
2 EX-5.1 d319880dex51.htm EX-5.1 6951
3 EX-10.1 d319880dex101.htm EX-10.1 161322
4 EX-99.1 d319880dex991.htm EX-99.1 17449
5 GRAPHIC g319880g57l58.jpg GRAPHIC 13712
6 GRAPHIC g319880g61o79.jpg GRAPHIC 12484
7 GRAPHIC g319880snap1.jpg GRAPHIC 7906
  Complete submission text file 0001193125-17-023883.txt   262602
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 17558541
SIC: 2834 Pharmaceutical Preparations